As of 2025-01-16, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 88.64 USD. This relative valuation is based on P/E multiples. With the latest stock price at 110.28 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is -19.6%.
The range of the Relative Valuation is 63.65 - 104.66 USD.
| Range | Selected | |
| Trailing P/E multiples | 36.6x - 43.7x | 40.2x |
| Forward P/E multiples | 22.8x - 35.3x | 29.0x |
| Fair Price | 63.65 - 104.66 | 88.64 |
| Upside | -42.3% - -5.1% | -19.6% |
| Date | P/E |
| 2025-01-15 | 46.07 |
| 2025-01-14 | 45.35 |
| 2025-01-13 | 44.22 |
| 2025-01-10 | 44.40 |
| 2025-01-08 | 46.19 |
| 2025-01-07 | 46.08 |
| 2025-01-06 | 45.08 |
| 2025-01-03 | 46.18 |
| 2025-01-02 | 45.29 |
| 2024-12-31 | 44.76 |
| 2024-12-30 | 44.18 |
| 2024-12-27 | 45.61 |
| 2024-12-26 | 47.73 |
| 2024-12-24 | 47.36 |
| 2024-12-23 | 47.54 |
| 2024-12-20 | 47.89 |
| 2024-12-19 | 47.60 |
| 2024-12-18 | 47.79 |
| 2024-12-17 | 50.31 |
| 2024-12-16 | 51.11 |
| 2024-12-13 | 48.84 |
| 2024-12-12 | 47.42 |
| 2024-12-11 | 50.28 |
| 2024-12-10 | 49.54 |
| 2024-12-09 | 48.60 |
| 2024-12-06 | 52.15 |
| 2024-12-05 | 51.59 |
| 2024-12-04 | 50.54 |
| 2024-12-03 | 50.10 |
| 2024-12-02 | 51.26 |
| 2024-11-29 | 50.74 |
| 2024-11-27 | 51.19 |
| 2024-11-26 | 51.94 |
| 2024-11-25 | 50.39 |
| 2024-11-22 | 49.79 |
| 2024-11-21 | 48.69 |
| 2024-11-20 | 46.60 |
| 2024-11-19 | 46.70 |
| 2024-11-18 | 46.65 |
| 2024-11-15 | 46.67 |
| 2024-11-14 | 48.23 |
| 2024-11-13 | 51.00 |
| 2024-11-12 | 50.44 |
| 2024-11-11 | 51.58 |
| 2024-11-08 | 50.65 |
| 2024-11-07 | 54.26 |
| 2024-11-06 | 48.83 |
| 2024-11-05 | 46.42 |
| 2024-11-04 | 46.04 |
| 2024-11-01 | 45.97 |